1ZL

Zai Lab Limited

Healthcare · EUR · F

1ZL

Price

€15.733

-0.41%

Cap

€2.09B

Earnings

30d Trend

-22.5%

1ZL
Loading chart data...
0 days · % change from startPowered by Brain47
VolatilityHigh

53% annualised over 90 days

BRAIN47 SIGNAL

0
WEAK
Risk Level85
Quality34
Momentum36
Technical39
Fundamentals50

Raw weighted: 33×Macro 0.99 (1%)=33

RISK

85/100
90d Volatility
53.4%High
ATR %
5.2%High daily moves
Max Drawdown (1Y)
-62.1%Volatile

QUALITY

34/100
ROE (avg)
-24.5%Negative
Piotroski F-Score
4/9Average
Accruals
-2.1%Cash earnings

MOMENTUM

36/100
12-1M Momentum
-22.7%Strong downtrend
6-1M Momentum
+7.2%Positive
1M Return
-15.6%Sharp decline

TECHNICAL

39/100
RSI (14)
41.5Neutral
Price vs SMA200
-19.3%Bearish trend
MACD
-0.17Bearish momentum
Bollinger Band
24%Mid-range
SMA Cross
Golden CrossGolden Cross
Trend Quality (KER)
0.297Noisy/choppy

FUNDAMENTALS

50/100

Macro: neutral (×0.99) - Fear/Greed: 64 (Greed) - Data: 80%

Running historical backtest...

BRAIN47 HORIZON ANALYSIS

<3 months38
3-12 months33
1-5+ years34

Limited short-term thesis

BRAIN47'S ASSESSMENT

I rate Zai Lab Limited at 33/100 — a WEAK reading on the Brain47 Signal. The strongest factor is fundamentals at 50/100. I classify this as a speculative position with the strongest thesis on a short-term horizon.

PAST PERFORMANCE

1 MONTH

-15.6%

3 MONTHS

-2.8%

12 MONTHS

-38.3%

Trailing returns — past performance, not a projection.

DETAILED ANALYSIS

Limited short-term thesis. Fundamentals (50) and Technical (39) are the primary strengths. I note an elevated risk profile — this warrants closer monitoring. Historical volatility is elevated at 53%. I classify this as a speculative position — elevated volatility at 53% and asymmetric payoff potential define the opportunity.

speculativeScore: 33/100

Want full analysis on every stock?

Brain47 provides AI-powered research across 72,000+ instruments. Stocks, ETFs, REITs and more.

Join Brain47 — Free

Generated by Brain47 AI. Educational research only. Not financial advice. Brain47 is not authorised by the FCA to provide investment advice.